0001579600-22-000001.txt : 20220906 0001579600-22-000001.hdr.sgml : 20220906 20220906113159 ACCESSION NUMBER: 0001579600-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220906 DATE AS OF CHANGE: 20220906 EFFECTIVENESS DATE: 20220906 FILER: COMPANY DATA: COMPANY CONFORMED NAME: T3D Therapeutics, Inc. CENTRAL INDEX KEY: 0001579600 IRS NUMBER: 461674269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-457972 FILM NUMBER: 221227437 BUSINESS ADDRESS: STREET 1: 1100 BEARGLADES LANE CITY: RALEIGH STATE: NC ZIP: 27615 BUSINESS PHONE: 919-949-0517 MAIL ADDRESS: STREET 1: 1100 BEARGLADES LANE CITY: RALEIGH STATE: NC ZIP: 27615 D 1 primary_doc.xml X0708 D LIVE 0001579600 T3D Therapeutics, Inc. 68 T.W. Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 919-949-0517 DELAWARE None None Corporation true John Didsbury 68 T.W. Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 Executive Officer Director Promoter Charles Lineberry 68 T.W. Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 Director Barry Buzogany 68 T.W. Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 Director John Golden 68 T.W. Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 Director Tom Mendell 68 T.W. Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 Director David Keim 68 T.W. Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 Director Donald Parker 68 T.W. Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 Director Pharmaceuticals Decline to Disclose 06b false 2022-08-26 false true false 0 7500000 6002712 1497288 false 23 0 0 0 Proceeds will be used for working capital which may include normal compensation to executive officers. false T3D Therapeutics, Inc. John Didsbury John Didsbury President and Chief Executive Officer 2022-09-03